Adaptive Biotechnologies Corp
NASDAQ:ADPT
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Price:
3.99 USD
5%
Market Closed
Updated:
May 14, 2024
Adaptive Biotechnologies Corp
Additional Paid In Capital
|
Adaptive Biotechnologies Corp
Additional Paid In Capital Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
Additional Paid In Capital
$1.5B
|
CAGR 3-Years
5%
|
CAGR 5-Years
105%
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Additional Paid In Capital
$17.3B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
8%
|
|
|
Danaher Corp
NYSE:DHR
|
Additional Paid In Capital
$14.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Additional Paid In Capital
$876.4m
|
CAGR 3-Years
3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
3%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Additional Paid In Capital
$5.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-5%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Additional Paid In Capital
$11B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
See Also
What is Adaptive Biotechnologies Corp's Additional Paid In Capital?
Additional Paid In Capital
1.5B
USD
1.5B
USD
Based on the financial report for Mar 31, 2024, Adaptive Biotechnologies Corp's Additional Paid In Capital amounts to 1.5B USD.
What is Adaptive Biotechnologies Corp's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
105%
105%
Over the last year, the Additional Paid In Capital growth was 5%. The average annual Additional Paid In Capital growth rates for Adaptive Biotechnologies Corp have been 5% over the past three years , 105% over the past five years .
You don't have any saved screeners yet
